Mario Gabelli Comments on C.R. Bard Inc.

Guru stock highlight

Author's Avatar
Aug 15, 2017

C.R. Bard Inc.(3% of net asset as of June 30 ,2017)(BCR–$316.11–NYSE)(NYSE:BCR) is a New Providence, New Jersey based medical equipment company that distributes diagnostic and patient care products. BCR agreed to be acquired by Becton Dickinson and Co. (BDX) on April 23, 2017 for $222.93 cash + 0.5077 BDX per share stock. The transaction requires regulatory and shareholder approvals and is expected to close in the fall of 2017.

From Mario Gabelli (Trades, Portfolio)'s second quarter 2017 Gabelli ABC Fund commentary.